CIBC Private Wealth Group
TPST icon

CIBC Private Wealth Group’s Tempest Therapeutics TPST Stock Holding History

CIBC Private Wealth Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.1K Buy
1,080
+620
+135% +$4.39K ﹤0.01% 2719
2025
Q3 		$4.73K Buy
460
+200
+77% +$1.74K ﹤0.01% 2575
2025
Q2 		$1.77K Buy
260
+250
+2,500% +$1.78K ﹤0.01% 2671
2025
Q1 		$67 Hold
10
– – ﹤0.01% 3007
2024
Q4 		$131 Hold
10
– – ﹤0.01% 2906
2024
Q3 		$186 Hold
10
– – ﹤0.01% 3026
2024
Q2 		$279 Hold
10
– – ﹤0.01% 3029
2024
Q1 		$724 Buy
+10
New +$505 ﹤0.01% 2894

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

CIBC Private Wealth Group's TPST Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Tempest Therapeutics (TPST) stake by 135% in Q4 2025, buying an estimated $4.39K and bringing the position to 1,080 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

CIBC Private Wealth Group first reported a position in TPST in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.73K in Q3 2025. 21 funds tracked by Wall St. Rank hold TPST as of Q4 2025.

  • CIBC Private Wealth Group held 1,080 shares of Tempest Therapeutics worth $3.1K as of Q4 2025.
  • CIBC Private Wealth Group bought 620 Tempest Therapeutics shares in Q4 2025, an estimated $4.39K.
  • Tempest Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2719 holding.
  • CIBC Private Wealth Group first reported a position in Tempest Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Tempest Therapeutics position peaked at $4.73K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.